Pharmacodynamic Biomarkers Global and China Top Players Market

Pharmacodynamic (PD) Biomarkers - Global and China Top Players Market Share and Ranking 2025

Pharmacodynamic Biomarkers Global and China Top Players Market

Pharmacodynamic (PD) Biomarkers - Global and China Top Players Market Share and Ranking 2025

Exclusive deal : 20% Instant discount on Direct purchases! Don't wait—claim your discount today!

Pharmacodynamic (PD) Biomarkers Market Size and Forecast 2024 to 2031

• The global Pharmacodynamic (PD) Biomarkers market was valued at US$ XX Million in 2024
• It is estimated to expand at a CAGR of % from 2024 to 2031
• The global Pharmacodynamic (PD) Biomarkers market is expected to reach the value of US$ XX Million by the end of 2031



The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report studies and analyses global Pharmacodynamic (PD) Biomarkers status and future trends, helping the client to determine the Pharmacodynamic (PD) Biomarkers market size of the total market opportunity by Type, by Application, by company, and by region & country. This report is a detailed and comprehensive analysis of the world market for Pharmacodynamic (PD) Biomarkers. It provides market size (in K Units & US$ million) and Year-over-Year growth, considering 2024 as the base year. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments. To assess the competitive environment within the market, including supplier revenue, market share, and company profiles.

Pharmacodynamic (PD) Biomarkers Market Key Takeaways

(1) Global Pharmacodynamic (PD) Biomarkers market size, history data 2020-2024 , and forecast data 2024 -2031, (US$ million) & (K Units)
(2) Global Pharmacodynamic (PD) Biomarkers sales, revenue, price by company, market share, and industry ranking 2020-2024, (US$ million) & (K Units)
(3) China Pharmacodynamic (PD) Biomarkers sales, revenue, price by company, market share, and industry ranking 2020-2024, (US$ million) & (K Units)
(4) Global Pharmacodynamic (PD) Biomarkers key consuming regions, consumption quantity, consumption value, and demand structure
(5) Global Pharmacodynamic (PD) Biomarkers key producing regions, capacity, production, and year-over-year growth
(6) Pharmacodynamic (PD) Biomarkers industry chains, upstream, midstream, and downstream

Pharmacodynamic (PD) Biomarkers Market: Key Players

The competitive landscape of the Pharmacodynamic (PD) Biomarkers Market offers a comprehensive analysis of key players. It includes insights such as company overviews, financial performance, revenue generation, market potential, research and development investments, new market strategies, regional presence, strengths and weaknesses, product launches, product range, and application leadership. These data points specifically pertain to the companies' activities and focus within the Pharmacodynamic (PD) Biomarkers Market. Some of the major players operating in the Pharmacodynamic (PD) Biomarkers Market are:
  • Thermo Fisher Scientific
  • Merck
  • Bio-Rad Laboratories
  • QIAGEN
  • Roche
  • Danaher Corporation
  • Siemens Healthcare
  • Abbott
  • Agilent Technologies


Market IntelliX's study on the Pharmacodynamic (PD) Biomarkers market offers information divided into important segments — type, applications, end-use, and region. This report provides comprehensive data and information about the important market dynamics and growth parameters associated with these categories.

Pharmacodynamic (PD) Biomarkers Market by Type [Analysis by Value from 2020 to 2031]:
  • Exposure Biomarkers
  • Effect Biomarkers
  • Susceptibility Biomarkers


Pharmacodynamic (PD) Biomarkers Market by Application [Analysis by Value from 2020 to 2031]:
  • Diagnostics
  • Drug Discovery
  • Personalized Medicine
  • Others


Pharmacodynamic (PD) Biomarkers Market by Region [Analysis by Value from 2020 to 2031]:
  • North America (United States, Canada and Mexico)
  • Europe (Germany, UK, France, Italy, Russia and Spain etc.)
  • Asia-Pacific (China, Japan, Korea, India, Australia and Southeast Asia etc.)
  • South America (Brazil, Argentina and Colombia etc.)
  • Middle East & Africa (South Africa, UAE and Saudi Arabia etc.)


Pharmacodynamic (PD) Biomarkers Market Report Includes:

Chapter 1: To describe Pharmacodynamic (PD) Biomarkers product scope, global sales quantity, value and average price, China sales quantity, value and average price, development opportunities, challenges, trends, and policies.

Chapter 2: Global Pharmacodynamic (PD) Biomarkers market share and ranking of major manufacturers, sales quantity, revenue, average price, 2020-2024

Chapter 3: China Pharmacodynamic (PD) Biomarkers market share and ranking of major manufacturers, sales quantity, revenue, average price, 2020-2024

Chapter 4: Global key producing regions of Pharmacodynamic (PD) Biomarkers , percent & CAGR, 2020 - 2031

Chapter 5: Pharmacodynamic (PD) Biomarkers industry chain, upstream, medium-stream, and downstream.

Chapter 6: Segment by Type, sales quantity, average price, consumption value, percent & CAGR, 2020 - 2031

Chapter 7: Segment by Application, sales quantity, average price, consumption value, percent & CAGR, 2020 - 2031

Chapter 8: Segment in regional level, sales quantity, average price, consumption value, percent & CAGR, 2020 - 2031

Chapter 9: Segment in country level, sales quantity, average price, consumption value, percent & CAGR, 2020 - 2031

Chapter 10: Company profile, introducing the basic situation of the main companies in the market in detail, including product specifications, application, recent development, sales quantity, average price, revenue, and gross margin.

Chapter 11: Conclusions

1 Market Overview

1.1 Pharmacodynamic (PD) Biomarkers Definition

1.2 Global Pharmacodynamic (PD) Biomarkers Market Size and Forecast

1.3 China Pharmacodynamic (PD) Biomarkers Market Size and Forecast

1.4 Share of China Pharmacodynamic (PD) Biomarkers Market with Respect to the Global Market

1.5 Pharmacodynamic (PD) Biomarkers Market Size: China VS Global Growth Rate, 2020-2031

1.6 Pharmacodynamic (PD) Biomarkers Market Dynamics

1.6.1 Pharmacodynamic (PD) Biomarkers Market Drivers

1.6.2 Pharmacodynamic (PD) Biomarkers Market Restraints

1.6.3 Pharmacodynamic (PD) Biomarkers Industry Trends

1.6.4 Pharmacodynamic (PD) Biomarkers Industry Policy

2 Global Leading Players and Market Share

2.1 By Revenue of Pharmacodynamic (PD) Biomarkers, Global Market Share by Company, 2020-2025

2.2 Global Pharmacodynamic (PD) Biomarkers Participants, Market Position (Tier 1, Tier 2, and Tier 3)

2.3 Global Pharmacodynamic (PD) Biomarkers Concentration Ratio

2.4 Global Pharmacodynamic (PD) Biomarkers Mergers & Acquisitions, Expansion Plans

2.5 Global Pharmacodynamic (PD) Biomarkers Major Companies Product Type

2.6 Head Office and Area Served of Key Players

3 China Leading Players, Market Share and Ranking

3.1 By Revenue of Pharmacodynamic (PD) Biomarkers, China Market Share by Company, 2020-2025

3.2 China Pharmacodynamic (PD) Biomarkers Pharmacodynamic (PD) Biomarkers Participants, Market Position (Tier 1, Tier 2, and Tier 3)

4 Industry Chain Analysis

4.1 Pharmacodynamic (PD) Biomarkers Industry Chain

4.2 Pharmacodynamic (PD) Biomarkers Upstream Analysis

4.2.1 Pharmacodynamic (PD) Biomarkers Core Raw Materials

4.2.2 Main Manufacturers of Pharmacodynamic (PD) Biomarkers Core Raw Materials

4.3 Midstream Analysis

4.4 Downstream Analysis

4.5 Pharmacodynamic (PD) Biomarkers Production Mode

4.6 Pharmacodynamic (PD) Biomarkers Procurement Model

4.7 Pharmacodynamic (PD) Biomarkers Industry Sales Model and Sales Channels

4.7.1 Pharmacodynamic (PD) Biomarkers Sales Model

4.7.2 Pharmacodynamic (PD) Biomarkers Typical Distributors

5 Sights by Type

5.1 Pharmacodynamic (PD) Biomarkers Classification

5.1.1 Exposure Biomarkers

5.1.2 Effect Biomarkers

5.1.3 Susceptibility Biomarkers

5.2 by Type, Global Pharmacodynamic (PD) Biomarkers Consumption Value & CAGR, 2020 VS 2024 VS 2031

5.3 by Type, Global Pharmacodynamic (PD) Biomarkers Consumption Value, 2020-2031

6 Sights by Application

6.1 Pharmacodynamic (PD) Biomarkers Segment by Application

6.1.1 Diagnostics

6.1.2 Drug Discovery

6.1.3 Personalized Medicine

6.1.4 Others

6.2 by Application, Global Pharmacodynamic (PD) Biomarkers Consumption Value & CAGR, 2020 VS 2024 VS 2031

6.3 by Application, Global Pharmacodynamic (PD) Biomarkers Consumption Value, 2020-2031

7 Sales Sights by Region

7.1 By Region, Global Pharmacodynamic (PD) Biomarkers Consumption Value, 2020 VS 2024 VS 2031

7.2 By Region, Global Pharmacodynamic (PD) Biomarkers Consumption Value, 2020-2031

7.3 North America

7.3.1 North America Pharmacodynamic (PD) Biomarkers Market Size & Forecasts, 2020-2031

7.3.2 By Country, North America Pharmacodynamic (PD) Biomarkers Market Size Market Share

7.4 Europe

7.4.1 Europe Pharmacodynamic (PD) Biomarkers Market Size & Forecasts, 2020-2031

7.4.2 By Country, Europe Pharmacodynamic (PD) Biomarkers Market Size Market Share

7.5 Asia Pacific

7.5.1 Asia Pacific Pharmacodynamic (PD) Biomarkers Market Size & Forecasts, 2020-2031

7.5.2 By Country/Region, Asia Pacific Pharmacodynamic (PD) Biomarkers Market Size Market Share

7.6 South America

7.6.1 South AmericaPharmacodynamic (PD) Biomarkers Market Size & Forecasts, 2020-2031

7.6.2 By Country, South America Pharmacodynamic (PD) Biomarkers Market Size Market Share

7.7 Middle East & Africa

8 Sales Sights by Country Level

8.1 By Country, Global Pharmacodynamic (PD) Biomarkers Market Size & CAGR, 2020 VS 2024 VS 2031

8.2 By Country, Global Pharmacodynamic (PD) Biomarkers Consumption Value, 2020-2031

8.3 United States

8.3.1 United States Pharmacodynamic (PD) Biomarkers Market Size, 2020-2031

8.3.2 by Type, United States Pharmacodynamic (PD) Biomarkers Consumption Value Market Share, 2024 VS 2031

8.3.3 by Application, United States Pharmacodynamic (PD) Biomarkers Consumption Value Market Share, 2024 VS 2031

8.4 Europe

8.4.1 Europe Pharmacodynamic (PD) Biomarkers Market Size, 2020-2031

8.4.2 by Type, Europe Pharmacodynamic (PD) Biomarkers Consumption Value Market Share, 2024 VS 2031

8.4.3 by Application, Europe Pharmacodynamic (PD) Biomarkers Consumption Value Market Share, 2024 VS 2031

8.5 China

8.5.1 China Pharmacodynamic (PD) Biomarkers Market Size, 2020-2031

8.5.2 by Type, China Pharmacodynamic (PD) Biomarkers Consumption Value Market Share, 2024 VS 2031

8.5.3 by Application, China Pharmacodynamic (PD) Biomarkers Consumption Value Market Share, 2024 VS 2031

8.6 Japan

8.6.1 Japan Pharmacodynamic (PD) Biomarkers Market Size, 2020-2031

8.6.2 by Type, Japan Pharmacodynamic (PD) Biomarkers Consumption Value Market Share, 2024 VS 2031

8.6.3 by Application, Japan Pharmacodynamic (PD) Biomarkers Consumption Value Market Share, 2024 VS 2031

8.7 South Korea

8.7.1 South Korea Pharmacodynamic (PD) Biomarkers Market Size, 2020-2031

8.7.2 by Type, South Korea Pharmacodynamic (PD) Biomarkers Consumption Value Market Share, 2024 VS 2031

8.7.3 by Application, South Korea Pharmacodynamic (PD) Biomarkers Consumption Value Market Share, 2024 VS 2031

8.8 Southeast Asia

8.8.1 Southeast Asia Pharmacodynamic (PD) Biomarkers Market Size, 2020-2031

8.8.2 by Type, Southeast Asia Pharmacodynamic (PD) Biomarkers Consumption Value Market Share, 2024 VS 2031

8.8.3 by Application, Southeast Asia Pharmacodynamic (PD) Biomarkers Consumption Value Market Share, 2024 VS 2031

8.9 India

8.9.1 India Pharmacodynamic (PD) Biomarkers Market Size, 2020-2031

8.9.2 by Type, India Pharmacodynamic (PD) Biomarkers Consumption Value Market Share, 2024 VS 2031

8.9.3 by Application, India Pharmacodynamic (PD) Biomarkers Consumption Value Market Share, 2024 VS 2031

8.10 Middle East & Africa

8.10.1 Middle East & Africa Pharmacodynamic (PD) Biomarkers Market Size, 2020-2031

8.10.2 by Type, Middle East & Africa Pharmacodynamic (PD) Biomarkers Consumption Value Market Share, 2024 VS 2031

8.10.3 by Application, Middle East & Africa Pharmacodynamic (PD) Biomarkers Consumption Value Market Share, 2024 VS 2031

9 Company Profile

9.1 Thermo Fisher Scientific

9.1.1 Thermo Fisher Scientific Company Information, Head Office, Market Area, and Industry Position

9.1.2 Thermo Fisher Scientific Company Profile and Main Business

9.1.3 Thermo Fisher Scientific Pharmacodynamic (PD) Biomarkers Models, Specifications, and Application

9.1.4 Thermo Fisher Scientific Pharmacodynamic (PD) Biomarkers Revenue and Gross Margin, 2020-2025

9.1.5 Thermo Fisher Scientific Recent Developments

9.2 Merck

9.2.1 Merck Company Information, Head Office, Market Area, and Industry Position

9.2.2 Merck Company Profile and Main Business

9.2.3 Merck Pharmacodynamic (PD) Biomarkers Models, Specifications, and Application

9.2.4 Merck Pharmacodynamic (PD) Biomarkers Revenue and Gross Margin, 2020-2025

9.2.5 Merck Recent Developments

9.3 Bio-Rad Laboratories

9.3.1 Bio-Rad Laboratories Company Information, Head Office, Market Area, and Industry Position

9.3.2 Bio-Rad Laboratories Company Profile and Main Business

9.3.3 Bio-Rad Laboratories Pharmacodynamic (PD) Biomarkers Models, Specifications, and Application

9.3.4 Bio-Rad Laboratories Pharmacodynamic (PD) Biomarkers Revenue and Gross Margin, 2020-2025

9.3.5 Bio-Rad Laboratories Recent Developments

9.4 QIAGEN

9.4.1 QIAGEN Company Information, Head Office, Market Area, and Industry Position

9.4.2 QIAGEN Company Profile and Main Business

9.4.3 QIAGEN Pharmacodynamic (PD) Biomarkers Models, Specifications, and Application

9.4.4 QIAGEN Pharmacodynamic (PD) Biomarkers Revenue and Gross Margin, 2020-2025

9.4.5 QIAGEN Recent Developments

9.5 Roche

9.5.1 Roche Company Information, Head Office, Market Area, and Industry Position

9.5.2 Roche Company Profile and Main Business

9.5.3 Roche Pharmacodynamic (PD) Biomarkers Models, Specifications, and Application

9.5.4 Roche Pharmacodynamic (PD) Biomarkers Revenue and Gross Margin, 2020-2025

9.5.5 Roche Recent Developments

9.6 Danaher Corporation

9.6.1 Danaher Corporation Company Information, Head Office, Market Area, and Industry Position

9.6.2 Danaher Corporation Company Profile and Main Business

9.6.3 Danaher Corporation Pharmacodynamic (PD) Biomarkers Models, Specifications, and Application

9.6.4 Danaher Corporation Pharmacodynamic (PD) Biomarkers Revenue and Gross Margin, 2020-2025

9.6.5 Danaher Corporation Recent Developments

9.7 Siemens Healthcare

9.7.1 Siemens Healthcare Company Information, Head Office, Market Area, and Industry Position

9.7.2 Siemens Healthcare Company Profile and Main Business

9.7.3 Siemens Healthcare Pharmacodynamic (PD) Biomarkers Models, Specifications, and Application

9.7.4 Siemens Healthcare Pharmacodynamic (PD) Biomarkers Revenue and Gross Margin, 2020-2025

9.7.5 Siemens Healthcare Recent Developments

9.8 Abbott

9.8.1 Abbott Company Information, Head Office, Market Area, and Industry Position

9.8.2 Abbott Company Profile and Main Business

9.8.3 Abbott Pharmacodynamic (PD) Biomarkers Models, Specifications, and Application

9.8.4 Abbott Pharmacodynamic (PD) Biomarkers Revenue and Gross Margin, 2020-2025

9.8.5 Abbott Recent Developments

9.9 Agilent Technologies

9.9.1 Agilent Technologies Company Information, Head Office, Market Area, and Industry Position

9.9.2 Agilent Technologies Company Profile and Main Business

9.9.3 Agilent Technologies Pharmacodynamic (PD) Biomarkers Models, Specifications, and Application

9.9.4 Agilent Technologies Pharmacodynamic (PD) Biomarkers Revenue and Gross Margin, 2020-2025

9.9.5 Agilent Technologies Recent Developments

10 Conclusion

11 Appendix

11.1 Research Methodology

11.2 Data Source

11.2.1 Secondary Sources

11.2.2 Primary Sources

11.3 Market Estimation Model

11.4 Disclaimer

Tables & Figures:
Show more
Research Methodology:
This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.
Pharmacodynamic (PD) Biomarkers Market Size Estimation

To estimate market size and trends, we use a combination of top-down and bottom-up methods. This allows us to evaluate the market from various perspectives—by company, region, product type, and end users.

Our estimates are based on actual sales data, excluding any discounts. Segment breakdowns and market shares are calculated using weighted averages based on usage rates and average prices. Regional insights are determined by how widely a product or service is adopted in each area.

Key companies are identified through secondary sources like industry reports and company filings. We then verify revenue estimates and other key data points through primary research, including interviews with industry experts, company executives, and decision-makers.

We take into account all relevant factors that could influence the market and validate our findings with real-world input. Our final insights combine both qualitative and quantitative data to provide a well-rounded view. Please note, these estimates do not account for unexpected changes such as inflation, economic downturns, or policy shifts.

Data Source

Secondary Sources

This study draws on a wide range of secondary sources, including press releases, annual reports, non-profit organizations, industry associations, government agencies, and customs data. We also referred to reputable databases and directories such as Bloomberg, Wind Info, Hoovers, Factiva, Trading Economics, Statista, and others. Additional references include investor presentations, company filings (e.g., SEC), economic data, and documents from regulatory and industry bodies.

These sources were used to gather technical and market-focused insights, identify key players, analyze market segmentation and classification, and track major trends and developments across industries.

Market Size
  • Segmental value
  • Geographic Penetration
  • Product Adoption Rate for Different market
  • Journals, Websites, and Press Releases
  • Annual Reports and SEC Filings
  • Company Websites and Press Releases
  • Public and Paid Databases
  • Market Intellix Data Repository
Market Position of Top Company
  • Product Financials
  • Geographic value Mix
  • Total Company value
  • Business/Segmental value Mix
Qualitative Analysis
  • Influence Factors
  • Market Potential
  • Market Risks and Opportunities
  • Industry Trends
  • Geographical Features
  • Government Policies
  • Company Websites and Press Releases
  • Public and Paid Databases
  • Annual Reports
  • Industry Associations
  • Market Intellix Data Repository

Primary Sources

As part of our primary research, we interviewed a variety of stakeholders from both the supply and demand sides to gather valuable qualitative and quantitative insights.

On the supply side, we spoke with product manufacturers, competitors, industry experts, research institutions, distributors, traders, and raw material suppliers. On the demand side, we engaged with business leaders, marketing and sales heads, technology and innovation directors, supply chain executives, and end users across key organizations.

These conversations helped us better understand market segmentation, pricing, applications, leading players, supply chains, demand trends, industry outlook, and key market dynamics—including risks, opportunities, barriers, and strategic developments.

Key Data Information from Primary Sources

Primary Sources Parameters Key Data
Market Segments(by Application, by Type)
  • Value by Type
  • Status and Forecast
  • Value by Application
  • Value by Regions, Status and Forecast (2025-2031)
  • Value Market Share by Type
  • Value Growth Rate by Type
  • Value by Application
  • Percentage and Growth Rate by Application
  • Value Growth Rate and Market Share by Regions
  • Market Size Status and Forecast (2025-2031)
Total Market
  • Overall Size, Status and Forecast
  • Market Size Status and Forecast (2025-2031)
Frequently asked questions(FAQ's):
Why is the Pharmacodynamic (PD) Biomarkers Market trending toward high growth trajectories?
A dynamic process in the Pharmacodynamic (PD) Biomarkers Market is initiated by new entrants, including competitors from unrelated industries, in addition to the established players like Thermo Fisher Scientific Merck Bio-Rad Laboratories QIAGEN Roche Danaher Corporation Siemens Healthcare Abbott Agilent Technologies.
How competitive is the Pharmacodynamic (PD) Biomarkers Market going to be?
The strategic moves of the Pharmacodynamic (PD) Biomarkers Market players such as Thermo Fisher Scientific Merck Bio-Rad Laboratories QIAGEN Roche Danaher Corporation Siemens Healthcare Abbott Agilent Technologies, and others clearly highlight consumer-centric strategies that use technology to improve customer experience.
What are the major applications of the Pharmacodynamic (PD) Biomarkers Market?
Depending upon the type of applications, the Pharmacodynamic (PD) Biomarkers Market has been segmented into and other applications.
What is the market value of the Pharmacodynamic (PD) Biomarkers Industry?
In 2024, the Pharmacodynamic (PD) Biomarkers Market share exceeded USD xx million. Between 2025 and 2030, it will grow at a CAGR of yy%.
What are the underlying opportunities in the Pharmacodynamic (PD) Biomarkers Market?
The influx of capital into the Pharmacodynamic (PD) Biomarkers Market, as well as the deployment of technologies designed to increase efficiency and yield high volume, are paving the way for promising market opportunities.
What is the CAGR at which the Pharmacodynamic (PD) Biomarkers Market can expand?
During the forecast years, the Pharmacodynamic (PD) Biomarkers Market can thrive with a robust CAGR.